Ranking Profile - Histogen Inc

Introduction

Histogen Inc (Histogen), formerly Conatus Pharmaceuticals Inc is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the activity of human caspases and is intended for the treatment of various indications such as post-orthotopic liver transplant, nonalcoholic steatohepatitis (NASH) cirrhosis, and NASH fibrosis. Its other preclinical product candidates include IDN-7314, a pan-caspase inhibitor intended for the treatment of primary sclerosing cholangitis. Histogen is headquartered in San Diego, California, the US.